A new therapy for genetic hearing loss has just been approved by the Food and Drug Administration (FDA). The treatment, Otarmeni (lunsotogene parvec-cwha), is the first-ever dual adeno-associated ...
On April 23, the Food and Drug Administration approved the first-ever gene therapy for a rare, congenital form of deafness. The treatment’s maker, biotechnology company Regeneron, says it plans to ...
In a worldwide first, a one-and-done gene therapy has been approved to treat a form of hereditary deafness. Many of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results